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The aim of present study was to assess therapeutic potential of traditional turmeric pickle by characterizing the potential 
health boosting probiotics present in it and recommend it as an attractive food supplement. Probiotics TP1, TP2 and TP3 
isolated from turmeric pickle had shown good antagonistic activity against all test pathogens i.e., Listeria monocytogenes, 
Bacillus cereus and Staphylococcus aureus with 100% inhibition. Most potential strain amongst them was identified as 
Enterococcus durans TP2 strain by 16S rRNA gene technique. Further safety assessment was confirmed by evaluating 
haemolytic activity, DNase and gelatinase activities and all the three probiotic isolates TP1, TP2 and TP3 had shown -ve 
results, thereby proving their completely safe status. The strain exhibited high tolerance to acid with minimum cell survival 
of 39.24% after 180 min at pH 2.0, high bile salt tolerance expressed cell survival of 93.69% after 8 h at 2.0% bile salt 
concentration, exhibited satisfactory auto aggregation potential after 5 h i.e., higher than 40% and reveal the strong 
hydrophobicity. The strain TP2 also exhibited good antioxidant activity, depletion of sodium nitrite and cholesterol 
reduction and was found to be susceptible to most of the antibiotics used. These observations designate that Enterococcus 
durans TP2 [MH916769] as a good probiotic candidate for enhancing the further therapeutic potential of well known 
immunity booster – Turmeric in the fermented pickle, thus recommending it as highly beneficial product for health. 
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Recently, amidst the outbreak of pandemic – COVID 
19, immunity enhancing products have become of 
high interest amongst the consumers. Turmeric is one 
of the well- known immunity enhancers worldwide
1
. 
Repeated recommendations of Ayush to consume 
turmeric in different forms viz., golden milk and dried 
powder etc. are a few examples of them. In the 
present study a new product i.e., turmeric pickle can 
have tall claims over the other products due to 
presence of not only raw turmeric chunks added in it 
but also being doused with additional immunity 
enhancing probiotics in it, thus highly recommending 
it as one of the best amongst the list of immunity 
booster products available commercially at 
economical rates and can be prepared at home also 
due to its easy fermentation process. Probiotic is ‘live 
microorganisms which provides immense benefits to 
the health of human beings. Probiotics have great 
potential in medicine, prevention and treatment of 
gastrointestinal infections, inflammations and allergic 
reactions to enhance immunity
2
. Beneficial effects on 
the host health such as anticarcinogenic, antioxidants 
properties, cholesterol lowering properties, antiinfection 
properties, immune system improvement, minimizing 
lactose intolerance and enhancement of nutritional 
level have strongly been attributed to probiotics. 
Probiotic-based natural health products are mostly 
available commercially in the form of fermented 
products as well as dietary supplements and lactic 
acid bacteria are predominant flora among them due 
to their good probiotic activity and WHO designated 
GRAS status
3
. The majority of the probiotic enriched 
food products is classified as functional foods and 
represents a remarkable segment well recognized as 
immunity booster of upcoming market. The need of 
probiotic enriched functional foods especially in 
current scenario of Covid-19 is increasing rapidly due 
to arising awareness of consumers. In this scenario, 
traditional Indian turmeric pickle has immense 
potential to be considered as a strong immunity 
booster along with its appetizing taste. So keeping in 
view the medicinal properties of turmeric, the present 
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study was undertaken to prepare turmeric pickle as 
well as to establish therapeutic effect of potential 
fermenting probiotic strains present in it by their 
isolation, identification and characterization. 
 
Material and methods 
 
Process for the preparation of turmeric pickle 
 
Ingredients used  
Fresh turmeric rhizomes, mustard oil, lemon juice, 





Flow sheet of Turmeric pickle preparation method 
 
Isolation of fermenting lactic acid bacteria 
Isolation of fermenting lactic acid bacteria was 
done from turmeric pickle by using standard spread 





. 1ml sample from each dilution was mounted 
on sterilized MRS agar medium containing petriplates 
to isolate lactic acid bacteria as well as assess 
microbial load. 
 
Antimicrobial activity  
Spoilage causing bacteria viz. Bacillus cereus CRI 
(CRI, Kasauli), Listeria monocytogenes MTCC 839 
(IMTECH, Chandigarh) and Staphylococcus aureus 
(IGMC, Shimla) were used to study their antagonistic 
potential. Three potential lactic acid bacteria i.e., TP1, 
TP2, and TP3 were isolated from turmeric pickle. 
Antimicrobial activity of isolates TP1, TP2 and TP3 




Bacteriocin production: Well diffusion method  
Isolated lactic acid bacteria TP1, TP2 and TP3 
were further subjected to test their bacteriocin 
production by well diffusion method against test 
indicators i.e., Listeria monocytogenes MTCC 839, 
Staphylococcus aureus IGMC and Bacillus cereus 
CRI. 1.0 OD culture of each indicator (1 ml) was 
swabbed on nutrient agar plates by using sterilized 
cotton buds. Well of 7 mm diameter and 5 mm depth 
were prepared on the lawns laid in the nutrient agar 
plates. The culture supernatant was poured into the 
wells and the method was repeated with crude 
preparations of isolates against their respective 
indicators. The plates were kept for incubation at 
37
o
C for 24 h. The inhibition zones appeared around 




Molecular identification of isolate TP2 by 16S rRNA technique 
On the basis of highest antimicrobial activity and 
bacteriocin production molecular identification of 
potential lactic acid bacteria TP2 was done by 
applying 16S rRNA technique. Bacterial isolate TP2 
was grown overnight at 30
o
C in MRS broth. The 
DNA was isolated by using GeNei Genomic DNA 
isolation kit. Partial DNA fragment of the 16S rRNA 
was amplified by polymerase chain reaction (PCR). 
The universal primers used for amplification were 
27F (5' AGAGTTTGATCMTGGCTCAG 3') and 
1492R (5' TACGGYTACCTTGTTACGACTT 3'). 
The phylogeny and family of the bacterial strain was 
accessed using BLAST search and the sequences so 
obtained were submitted in Gen bank, National 
Center for Biotechnology Information (NCBI), US.  
 
Characterization of E. durans TP2 as potential probiotic and 
therapeutic agent 
A. Evaluation of safety assessments of Enterococcus 
durans TP2 [MH916769] 
 
DNase production  
DNase agar medium plates were prepared and spot 
inoculation of isolates was done and incubated at 
37
o
C for 24 h. 
 
Gelatinase production  
Gelatinase enzyme production was confirmed by 
inoculating 20 µL of 12 h old cultures on MRS agar 




plates supplemented with 3% gelatin and incubated at 
37
o
C for 24 h. Plates were flooded with ammonium 
sulphate solution. 
 
Haemolytic activity  
Haemolytic activity was assessed by spot 
inoculation of bacterial cultures on sheep blood agar 
plates enriched with 5% human blood and incubated 
at 37
o
C for 24 h. 
B. Primary characteristics of E. durans TP2 
[MH916769] 
 
Acid tolerance of E. durans TP2 
Acid tolerance of isolate E. durans TP2 was 




Bile salt tolerance E. durans TP2 
Bile salt tolerance was done following the method 




Antibiotic Sensitivity Test 
The antibiotic sensitivity was measured towards 
antibiotics viz. Nystatin (100 units), Ampicillin (10 µg), 
Ofloxacin (10 µg), Augmentin (10 µg), Co-trimoxazole 
(25 µg), Nalidixic acid (10 µg), Erthromycin (15 µg), 
Tetracycline (30 µg), Gentamycin (10 µg), , Novobiocin 
(10 µg), Fluconazole (25 µg), Kanamycin (10 µg), 
Ampicillin (10 µg), Sulphatriad (10 µg), , Vancomycin 
(10 µg), Chloramphenicol (10 µg) and Amoxicillin(10 
µg). Antibiotic discs were placed on seeded plates and 
the zone of inhibition was observed after 24 h of 
incubation at 35°C.  
 
Auto-aggregation and Co aggregation  
Auto-aggregation and co aggregation assay was 
performed as described by Zommiti et al.
7
. 
C. Therapeutic potential of E. durans TP2 
[MH916769] 
 
Bacterial adhesion to solvents: Hydrophobicity  
Microbial adhesion to hydrocarbons was measured 




Antioxidant properties: DPPH free radical scavenging assay  
Antioxidant properties of the cell free extract was 
measured and absorbance was read at 517 nm after 30 
min of incubation. The antioxidants activity was 
calculated by applying the equation [Ab517 C – Ab517 




In vitro cholesterol lowering property  
The capability of isolates to assimilate cholesterol 





Estimation of Siderophore production  
Screened probiotic isolates were checked for 
siderophore production by following the method of 
Schwyn and Neilands (1987)
11
. Observations were 
recorded. Formation of yellow orange zones around 





Determination of sodium nitrite depletion  
Sodium nitrite depletion by the isolates in  
MRS broth was determined. Nitrite depletion (%) = 
(1-C1/C0) x100, where C0 and C1 are the concentration 





Bile salt hydrolase activity  
Isolates were cultivated in medium supplemented 
with 0.2% glycocholic acid (GCA) and incubated at 
37ºC for 48 to 72 h. Plates were observed for the 
white precipitates.  
 
Results and Discussion 
 
Preparation of turmeric pickle and isolation of fermenting lactic 
acid bacteria from turmeric pickle 
Food fermentation is a traditional process of food 
preservation used since ancient times. Fermentation 
also improves the nutritional value of foods, increases 
digestibility of food and enhances flavor thus making 
these traditional foods more popular all over the 
world. India is well known for its fermented foods 
especially a variety of fermented pickles. Turmeric 
pickle is one of them. Turmeric itself has therapeutic 
properties and especially its most active concentrated 
compound curcumin has many scientifically proven 
health benefits such as being very powerful 
antioxidant, anti-inflammatory in nature and also 
beneficial to prevent heart disease and cancer. In the 
present study, turmeric pickle was prepared by using 
fresh rhizomes of turmeric collected from local 
market by the process of natural fermentation 
followed by isolation of many potential probiotic 
strains - TP1, TP2 and TP3 and their characterization. 
Morphologically TP1, TP2 and TP3 colonies 
appeared cream, white and cream coloured 
respectively with entire margin, raised elevation and 
smooth texture on MRS (Table 1). Biochemical tests 
viz., MRVP test, casein hydrolysis, indole production 
and H2S production were observed negative while 
fermentation of carbohydrates, citrate utilization and 
motility test were found positive for TP1, TP2 and 
TP3 and identified according to Bergey’s Manual  
of Determinative Bacteriology as Lactococcus sp  
(Table 2). Out of all the isolates, TP2 was identified 
by using 16S rRNA technique and sequence similarity 
search for the isolate TP2 was found 99% similar with 




the sequence of Enterococcus durans. So the 
isolateTP2 identified as Enterococcus durans TP2 and 
had assigned with the accession no [MH916769] by 
NCBI, US. 
All these isolates were having microbial load > 10
6
 
CFU/g of sample, thus fulfilling the criteria of WHO 
that recommends a product with 10
6
 CFU/g of load 
adequate to establish and colonize in a healthy gut for 
beneficial effects. Being fermenting microorganisms, 
lactic acid bacteria as probiotics are considered good 
for health with high therapeutic potential. Since most 
of them are recognized probiotics, but their health 
potential may vary from strain to strain and that’s why 
characterization to enlist their efficacy and viability is 
very important. Therefore, in the present study, all of 
three isolated lactic acid bacteria- TP1, TP2 and TP3 
were further evaluated to screen and characterize 
these fermenting LAB as robust probiotics and to 
assess their health potential. 
 
Antagonistic spectrum of isolated bacterial isolates 
Isolated LAB was further confirmed for their 
antagonistic spectrum against selected challenging 
pathogens viz., Listeria monocytogene, Bacillus 
cereus CRI and Staphylococcus aureus. Those 
isolates showing clear zones less than 9mm against 
the test strain indicated poor antimicrobial activity, 
while the strains which depicted halo zones of greater 
than 12 mm and 20 mm were shown to have 
appreciable and strong antimicrobial activity against 
the indicators (Fig. 1). Though all 3 fermenting 
isolated lactic acid bacteria had shown high 
antimicrobial potential but further their activity was 
compared to find out the best one amongst them to be 
used as a probiotic reference strain for further study. 
Out of 3 isolates, TP2 isolate was selected for its 
further identification on the molecular level. In a 
similar study, new Lactobacilli strains were isolated 






Fig. 1 — Antagonistic activities shown by TP1, TP2 and TP3 
 
Bacteriocin production 
In this study, three isolates TP1, TP2 and TP3 after 
testing their antagonistic spectrum were further 
subjected to check their bacteriocin production 
potential. Only one lactic acid bacteria i.e., TP2 was 
found positive for bacteriocin production where as 
TP1 and TP3 were observed negative (Table 3). A 
maximum zone size of 29 mm and 25 mm was 
depicted during the growth cycle of the isolate TP2, 
against S. aureus and L. monocytogenes respectively, 
after 44h of incubation at stationary phase (Fig. 2). 
Bacteriocin production is additional desirable trait of 
probiotics because of its antimicrobial nature and thus 
it is capable of inhibiting/ suppressing the growth of 
many challenging pathogens in the system
14
 (Fig. 3). 
 
Molecular identification of potential lactic acid bacteria TP2  
On the basis of highest antimicrobial activity and 
bacteriocin production, the best selected isolate TP2 
(Fig. 4) was studied on its molecular level by using 
16S rRNA approach. 16S rRNA sequences analysis 
revealed that TP2 strain isolated from turmeric pickle 
displayed 99% homology with Enterococcus durans 
Table 1 — Isolation of potential lactic acid bacteria from turmeric pickle and their morphological characteristics 
Sr. No. Isolates Food source Color Form Margin Elevation Texture 
1.  TP1 Turmeric pickle Cream Circular Entire Raised Smooth 
2.  TP2 Turmeric pickle White Circular Entire Raised Smooth 
3.  TP3 Turmeric pickle Cream Circular Entire Raised Smooth 
 
Table 2 — Biochemical characteristics of isolated bacteria and their tentative identification 
Sr No. Isolates Gram’s Staining Shape Catalase Mode of growth Tentative 
identification 
1.  TP1 +ve Cocci -ve Facultative anaerobe Lactococcus 
2.  TP2 +ve Cocci -ve Facultative anaerobe Lactococcus 
3.  TP3 +ve Cocci +ve Facultative anaerobe Lactococcus 
 




and indexed with accession number MH916769 in 
NCBI, US and its phylogenetic tree is presented in 
(Fig. 5). In literature identification of probiotic lactic 
acid bacteria on species level is being done on the 
basis of their biochemical and physiological 
characteristics according to Bergey’s manual of 
determinative bacteriology while confirmed 
authenticated identification is mediated only using 
16S rRNA gene technique. 
 
Probiotic potential of E. durans TP2 
A. Evaluation of safety assessment of E. durans TP2 
[MH916769] 
 
(i) DNase activity 
E. durans TP2 isolated in the present investigation 
was found to be negative for the production of DNase 
enzyme assigning a complete safe status to this isolate 
for further use (Fig. 6). Microorganism producing 
DNase enzyme cannot be used as a probiotic in food 
and feed industry. DNase is an extracellular enzyme 
which helps in the growth of pathogen by amplifying 
the pool of available nucleotides through DNA 
hydrolysis process and helps in dispersal of the 
pathogens. DNase also escapes the innate immune 





(ii) Gelatinase activity 
E. durans TP2 was assayed for gelatinase activity 
and there was absence of clear zone which indicated 
nil gelatinase activity, thus revealing its safe nature 
(Fig. 7). Gelatinases are the metalloproteinases 
produced by pathogenic bacteria which are capable of 




Table 3 — Bacteriocin production by potential of lactic acid bacteria 
   Zone size (mm) Average zone size 
(mm) Sr No. Isolates Bacteriocin production S. aureus (mm) L. monocytogens (mm) 
1.  TP1 - - - - 
2.  TP2 + 29 25 27 




Fig. 2 — Bacteriocin production by isolate lactic acid bacteriaTP2 




Fig. 3 — Bacteriocin production by E. durans TP2 during its 








Fig. 5 — Phylogenetic relationship of Enterococcus durans TP2 
(MH916769) based on a neighbor joining analysis of 16S rRNA 
sequences by MEGA 6.0 software 
 










Fig. 7 — Gelatinase activity: negative shown by E. durans TP2 
 
(iii) Haemolytic activity 
E. durans TP2 was found negative for haemolysis 
on blood agar plates. Absence of clear zones (α-
haemolysis) and green-hued zones (β-haemolysis) 
around colonies, thereby prove its safe and non-virulent 
nature (Fig. 8). A safe probiotic should be 
nonpathogenic as well as non-invasive hence 
elimination of pathogenic strains is essential for the 




B. Primary characterization of Enterococcus durans TP2 
[MH916769] 
 
(i) Acid and bile tolerance 
E. durans TP2 had tolerated pH 3 maximum upto 
77.53% after 180 min and shown minimum cell 
survival of 39.24% after 180min at pH 2.0. E. durans 
TP2 showed maximum log CFU/mL of 6.37 at pH 6.5 
and minimum log CFU/mL of 1.31 at pH 1.0 (Fig. 9). 
The exposure to pH 2.0 violently decreased the counts 
of LAB after 1 or 2 h of incubation period. When 
isolates were exposed to pH 5.0 and to bile salts (0.15, 
0.30 and 1.00%), there is nil decrease in the counts of 
the Lactobacillus strains. 
 
(ii) Antibiotic sensitivity 
E. durans TP2 was found to be sensitive for the 
most of antibiotics used in the present study (Table 4), 
thereby presenting its inability to show resistance  
in the presence of antibiotics and thus proving its  
safe status (Fig. 10). Mostly, LAB are sensitive to 
inhibitors of protein synthesis such as Erythromycin, 
Tetracycline, Chloramphenicol and Clindamycin and 
resistant to glycopeptides like Gentamycin, Kanamycin, 
Streptomycin, etc. The antibiotic susceptibility 
confirmed all these isolates as safe and thus proposes 
their use as potential probiotics successfully. 
According to world Health Organization bacteria used 
 
 




Fig. 9 — Acid tolerance of E. durans TP2 
 




as probiotics should not carry any transferable 
antibiotic resistance gene
17
. The presence of large 
number of transferable resistance genes within the 
intestinal microflora is unacceptable due to the risk 
caused by pathogens present in GI tract and following 
further failure of antibiotic treatment. Therefore, it is 
necessary to confirm that probiotic strains lack 
acquired antibiotic resistance characteristics to consider 
them safe for human and animal consumption
18
.  
Thus the sensitivity of these lactic acid bacteria 
minimizes the chances of dispersing the resistance 
genes to pathogens in the food matrix as well as in the 
GI tract. 
 
(iii) Auto aggregation and co aggregation  
E. durans TP2 exhibited highest auto-aggregation 
percentage (97.45) at 5 h of incubation period  
(Fig. 11). Bacterial aggregation between cells of the 
same strain (auto-aggregation) or between different 
species and strains (co-aggregation) is of significant 
importance and is one of the basic factors to check the 
potential of the probiotic strains to bind to the GI 
tract, where probiotics are to be vital and employ their 
favourable effects
19
. In the present study, E. durans 
TP2 showed highest coaggregation with B. cereus 
(16.6%) and lowest with L. monocytogenes (14.6%) 
(Fig. 12).  
Table 4 — Antibiotic sensitivity of E. durans TP2 
Antibiotics E. durans TP2 
Gentamycin (GEN) S 
Ofloxacin (OF) S 
Kanamycin (K) R 
Amoxicillin (AMX) S 
Augmentin (A) S 
Novobiocin (Nv) S 
Ampcillin (AMP) S 
Chloramphenicol(C) S 
Sulphatriad (S) R 
Tetracycline (TE) S 
Vancomycin (V) S 
Erythromycin (E) S 
Co-trimoxazole(COT) S 
Nystatin (N) S 
Fluconazole (FLC) S 
Nalidixic acid (NA) S 













Fig. 12 — Coaggregation of E. durans TP2 showed by different 
indicators 
 




C. Therapeutic potential of E. durans TP2 [MH916769] 
 
Cell surface hydrophobicity  
Cell surface hydrophobicity is a nonspecific 
interaction between microbial cells and host. E. durans 
TP2 exhibited maximum adhesion i.e., 94.39% 
towards xylene, 80.61% towards chloroform and 
86.73% towards ethyl acetate (Fig. 13). Bacterial 
adhesion to xylene, chloroform and ethyl acetate is 
tested to assess the Lewis acid-base characteristics of 
the bacterial cell surfaces
20
. The capability to bind 
with mucus and epithelial cells is an important criteria 
for a potential probiotic strain which make smooth 
adhesion to intestinal epithelium.  
 
Antioxidant activity 
Probiotic microorganisms express antioxidant 
potential by producing enzymes like superoxide 
dismutase (SOD) which encourage the production  
of non-enzymatic antioxidant and free radical  
scavenger glutathione (GSH) and certain antioxidant 
biomolecules. Antioxidants increase the body’s 
immune system and shield our cells from deleterious 
effects of free radicals. The antioxidant activity of the 
screened lactic acid bacteria i.e., E. durans TP2 was 
investigated through the DPPH scavenging ability of 
the cell free extracts had been recorded significantly 
high i.e., 63.78% proving it a very strong immunity 
booster. The antioxidant activity was observed with E. 
durans TP2 was 63.78%.  
 
Cholesterol lowering property  
High cholesterol level in the blood and diet is a 
crucial factor for cardiac disease and colon cancer. In 
this study, isolate E. durans TP2 was studied for 
cholesterol assimilation and found 68.56% cholesterol 
lowering property. Recently lactic acid bacteria have 
great attention towards worldwide as potential agent 
for cholesterol–lowering property. Utilization of 
fermented food products viz. dairy products having 
probiotics has been proposed as a mean to lower 
serum cholesterol. The depletion of serum cholesterol 
could be a prime health benefit of LAB for humans as 





Iron deficiency is more common in Indian 
population, which causes birth defects, anemia, 
cancer, etc. Hence, probiotic microorganisms also 
help to combat the deficiencies of iron. When the 
selected E. durans TP2 was subjected to siderophore 
production, it was found that it was able to produce 
zones on the plates supplemented with CAS (Chrome 
Azurol Sulfonate) dye depicting its ability for 
siderophore production. Panda et al., specified the 
Enterococcus strain isolated from dairy products as 





Sodium nitrite depletion test  
Nitrite is an important N-nitrosamines precursor, 
which has ability to cause methemoglobinemia and 
carcinogenesis. The control of Sodium nitrite 
concentration is important from the food safety point 
of view. LAB has been found to deplete nitrite in 
many fermented foods. E. durans TP2 strain showed 
good sodium nitrite depletion (73.58 %).  
 
Bile Salt hydrolase activity of E. durans TP2 
BSH activity is a desirable attribute of probiotics. 
LAB isolates are streaked on MRS plates containing 
taurine conjugated bile acid BSH, they produce bile 
salt hydrolase. The deconjugation activity of LAB 
isolate is displayed in plates and copious amounts of 
deoxycholic acid get precipitated around active 
colonies and diffused into the surrounding medium. In 
the present study E. durans TP2 showed white 
precipitation around the colonies marking it positive 
for bile salt hydrolase activity.  
The overall probiotic potential of bacterial strains 
is based upon their cumulative probiotic score 
achieved by it depending upon the different 
parameters evaluated in the present study. In this 
study probiotic potential of E. durans TP2 has 
exhibited an impressive probiotic score of 95.66% 
proving its worth as an outstanding probiotic for 
improving health and immunity. This prepared 
turmeric pickle had enhanced therapeutic effects due 
to the presence of probiotic which are already 
established immunity enhancers. In the wake of the 
Covid-19 pandemic outbreak, entire humanity across 
 
 
Fig. 13 — Hydrophobicity showed by E. durans TP2 strain with 
different hydrocarbons 




the world is suffering. Thus, increasing the body's 
immune system becomes a major goal of all of us in 
maintaining good health. The Ministry of AYUSH, 
Govt. of India issued some self-care guidelines as 
preventive health measures for boosting immunity 
with special reference to respiratory health amidst the 
coronavirus outbreak. According a traditional Indian 
system of treatment AYUSH recommended Golden 
Milk- (milk + turmeric), an Ayurveda medicine to 
promote immunity
23
. Curcumin is the active 
ingredient in turmeric; it has powerful biological 
properties as immunity boosters. So keeping in view 
the therapeutic importance of turmeric itself turmeric 
pickle – a concentrated product with the source of 
immunity booster probiotics is highly recommended 
for daily use to promote health of the consumers. 
 
Conclusions  
The present investigation was carried out to 
prepare a traditional fermented product- turmeric 
pickle followed by isolation of efficient potential 
probiotic microorganisms from turmeric pickle, their 
screening, identification, safety assessment as well as 
evaluation of probiotic attributes. Three lactic acid 
bacteria were isolated from fermented turmeric pickle 
and characterize as good probiotics and present  
in adequate load (>10
6
 CFU/g) as per WHO 
recommendation. Upon screening, a strain TP2 
identified as Enterococcus durans using 16S r RNA 
gene technique had shown high grade of 95.66% of 
probiotic score along with therapeutic potential. The 
potential lactic acid E. durans TP2 [MH916769] had 
good antioxidant activity led to depletion of sodium 
nitrite and cholesterol reduction. Probiotic when 
tested had shown high immunity boosting potential 
with antioxidant activity of ~ 64%. Turmeric itself 
established as a good immunity enhancer further 
coupled with health promoting probiotics in 
fermented pickle have turned this traditional pickle  
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